RECURSION PHARMACEUTICALS, INC. cotiza a 4.01 USD y tiene una capitalización bursátil de $2.2B. En los últimos 12 meses ha facturado $55M con un margen de flujo de caja libre del -506.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company de…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.25 | $-0.22 | $-0.21 |
| Estimado | $-0.23 | $-0.23 | $-0.26 | $-0.32 |
| Sorpresa | — | -8.7% | +15.4% | +34.4% |
| Métrica | RXRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 5.0% | 57.0% | -52.0% |
| Operating Margin | -867.9% | -38.6% | -829.3% |
| Net Margin | -863.4% | -33.6% | -829.8% |
| FCF Margin | -506.5% | -13.9% | -492.7% |
| ROE | -57.0% | -40.4% | -16.6% |
| ROA | -43.7% | -32.0% | -11.7% |
| Current Ratio | 5.50 | 2.84 | +2.66 |
| Debt / Equity | 0.01 | 0.28 | -0.27 |